Biotrol International, Inc. – Trademark Portfolio

Entity Type: 03

Biotrol International, Inc. holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include BIOCIDEG30. The owner is based in Louisville, CO.

650 South Taylor

Louisville, CO 80026

9 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Biotrol International, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (6 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

10
Medical Apparatus (3 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Biotrol International, Inc. have?

Biotrol International, Inc. has 9 U.S. trademarks filed with the USPTO. Of these, 1 registered, 8 abandoned.

What trademark classes does Biotrol International, Inc. file in?

Biotrol International, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Biotrol International, Inc.'s most well-known trademarks?

Biotrol International, Inc.'s registered trademark portfolio includes well-known marks such as BIOCIDEG30. These are among 1 currently registered trademark in the portfolio.

What is Biotrol International, Inc.'s trademark registration success rate?

Biotrol International, Inc. has a 11% trademark registration rate, with 1 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.